Roivant Sciences
ROIV
444 hedge funds and large institutions have $14.7B invested in Roivant Sciences in 2026 Q1 according to their latest regulatory filings, with 96 funds opening new positions, 175 increasing their positions, 121 reducing their positions, and 47 closing their positions.
104% more first-time investments, than exits
New positions opened: 96 | Existing positions closed: 47
45% more repeat investments, than reductions
Existing positions increased: 175 | Existing positions reduced: 121
33% more capital invested
Capital invested by funds: $11B → $14.7B (+$3.63B)
31% more call options, than puts
Call options by funds: $42M | Put options by funds: $32M
11% more funds holding
Funds holding: 399 → 444 (+45)
0.92% more ownership
Funds ownership: 73.17% → 74.08% (+0.92%)
0% more funds holding in top 10
Funds holding in top 10: 14 → 14 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$313M |
| 2 |
FCM
Farallon Capital Management
San Francisco,
California
|
+$248M |
| 3 |
DGM
Darwin Global Management
St. Helier,
Jersey
|
+$175M |
| 4 |
AQR Capital Management
Greenwich,
Connecticut
|
+$130M |
| 5 |
National Bank of Canada
Montreal,
Quebec, Canada
|
+$109M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SIAU
SB Investment Advisers (UK)
London,
United Kingdom
|
-$353M |
| 2 |
Morgan Stanley
New York
|
-$168M |
| 3 |
RCMNY
Rubric Capital Management (New York)
New York
|
-$103M |
| 4 |
JFG
Jefferies Financial Group
New York
|
-$90.1M |
| 5 |
O
OrbiMed
New York
|
-$47.5M |
ROIV Hedge Fund Activity: Q1 2026 in Review
444 of the 8,184 institutional investors tracked by Wall St. Rank reported a position in Roivant Sciences (ROIV) for Q1 2026, worth a combined $14.7B — up 33% from $11B a quarter earlier.
Buyers outnumbered sellers: 96 funds opened new ROIV positions and 47 closed out — a net gain of 49 holders — while 175 added to existing stakes and 121 trimmed.
The largest buyer was Fidelity Investments, adding an estimated $313M. The largest seller was SB Investment Advisers (UK), cutting an estimated $353M.
- 444 institutional investors held Roivant Sciences (ROIV) as of Q1 2026, up from 399 in Q4 2025.
- Funds reported $14.7B of Roivant Sciences stock for Q1 2026, up 33% quarter-over-quarter.
- 96 funds opened new Roivant Sciences positions in Q1 2026 and 47 closed out, a net change of +49 holders.
- The largest Roivant Sciences buyer in Q1 2026 was Fidelity Investments, an estimated $313M added.
- The largest Roivant Sciences seller in Q1 2026 was SB Investment Advisers (UK), an estimated $353M sold.
Based on aggregated 13F filings for Q1 2026.